Cymal-6 anagrade 250G, etc
Ended Purchase Order Awarded
- Contract number
- HHSN267200801180P
- Awardee
-
Anatrace, Inc. UEI XHKLFBKR5Z87
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $63,753
Award facts
- Contract value 100% obligated
-
- $63,752.92 Current, with exercised options
- $63,752.95 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325613 Surface Active Agent Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN267200801180P?
HHSN267200801180P was awarded to Anatrace, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 28, 2008.
How much is contract HHSN267200801180P worth?
The government has obligated $63,753 on HHSN267200801180P. Its potential value, with all options, is $63,753.
Was contract HHSN267200801180P competed?
The extent of competition for HHSN267200801180P was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award